Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

Xellar Biosystems

Xin Xie

The human body is a holistic system, its biology is multi-faceted and intricately interconnected. Traditional drug discovery and development efforts have relied on simplified models and reductionistic tools to discover and test new drugs. Now it's time to make a change. Xellar is a Wet-AI, Artificial Intelligence and machine learning combined with large-scale wet-lab experiments, biotech company tackling the most challenging problem in modern drug discovery - harnessing the complexity of human biology to accelerate drug discovery and development.

Bioinformatics Organizations

Software Companies

Artificial Intelligence Companies

TRIAPEX

Legend Capital

Tiantu Capital

Yael Capital

Zhengxuan Investment

Provider of innovative and innovative enterprises

Boston

Capital and largest city of Massachusetts, United States

United States of America

Country primarily located in North America

Greater Boston

Metropolitan area in Massachusetts, New Hampshire and Rhode Island, USA

Massachusetts

Suffolk County

Newton

Middlesex County

Cambridge

City in Middlesex County, Massachusetts, United States of America

Custom Computer Programming Services

Computer Systems Design and Related Services

Professional, Scientific, and Technical Services

Software Publishers

Publishing Industries

Information

Publishing Industries (except Internet)

Lisk

Platform that provides decentralized blockchain apps

Computer Programming Services

Computer Programming, Data Processing, And Other Computer Related

Business Services

Prepackaged Software

Polyfill

web-vitals

Sectigo

React

Google Cloud Platform

sentry

lodash

Xellar Biosystems Funding & Investors

Total Amount Raised: $13,760,647

Xellar Biosystems Funding Rounds

Seed Investors

💸 Investors

💻 Job Types

📚 Popular Blog Posts